EAT Displays is an adtech company that provides digital out-of-home advertising solutions in previously untapped, engaging retail environments such as foodcourts and airports. The company has turned the traditional table into a powerful innovative display unit that provides advertisers, retailers and others with an unparalleled opportunity to connect and engage with each other, at a time when consumers are at their most receptive and responsive – while taking time out to eat, drink, relax and charge their mobile devices.
The company has installed its globally patented smart table at 4 locations with LendLease and Dexus, has a contract to install with ISPT, and is in advanced stages with Sydney Airport and a number of other blue-chip clients as it expands its national footprint.
EAT Displays records and stores customer behaviour and demographics through concealed visual sensors, and has the ability to provide hypertargeted advertising content based on specific demographic features. This allows brands to reach target audiences in highly engaged, retail environments while store managers can gain deeper insights into customer behaviour.
The initial targets are shopping centres and airports, where people sit to eat and drink for prolonged periods, with a high propensity to spend. Average dwell time in food courts is 20 minutes; international airports is 120 minutes.
Section 708 disclosure: The issuer of the securities is EAT Displays Holdings Pty Ltd ACN 623 195 246. The securities to be issued are fully paid ordinary shares. The information provided on the OnMarket website has been prepared by EAT Displays Holdings Ltd, and OnMarket makes no representation as to its accuracy or completeness. No prospectus has been prepared and accordingly, the Offer is being made to sophisticated, experienced and professional investors only.
The offer close and the 'Pay By' dates may change. Duplicate bids under the same investment profile or investor name may be cancelled. If oversubscribed, applications will be scaled back on a pro rata basis.
Tap 'More Info' to get access to free research, all company releases, and invest instantly for shares.
Koligo Therapeutics Ltd (ASX: KOL) is a US biotechnology company focused on the development and commercialisation of a range of cell therapy, three-dimensional (3D) bioprinted tissue and other regenerative medicine products for serious unmet medical needs. Koligo has successfully commercialised and has commenced selling its first cell therapy transplant product, Kyslecel™, for the treatment of chronic pancreatitis patients, generating $1.6 million in revenue from sales of this product. Koligo is also working on other transformative cell therapies for a range of indications, including type 1 diabetes, and other pancreatic diseases.
Offer closed via OnMarket.
AXS Group Limited (ASX Code: AXS) is an integrated software solution provider to the finance, insurance and funds sector. With over 40 clients in Australia, North America, Europe and Asia they are focussed on helping clients with their digital transformation, reducing time and cutting costs. The Company’s cloud based ARMnet platform currently is used to manage over $100 billion of assets and transactions that are accessible via smart phones, tablets or email from anywhere at any time.
Offer closed early via OnMarket. Payments are now due by 5pm Friday 22 March.
Australian Nutrition & Sports Ltd (ASX: AN1) is focussed on the development, branding and distribution of its own high-quality milk formula, health and wellness products for sale in Australia, China, Hong Kong, with plans to expand into further Asian markets over time. Currently focused on infant and adult milk formula products, protein-based health and wellness nutritional supplements, the company has successfully commercialised a number of products in Hong Kong with distribution through ~350 pharmacies. Expansion into the Chinese market is supported by production agreements with export approved Australian manufacturers.